Microbix Biosystems Inc. (MBXBF)

Microbix Biosystems Income Statement

Financials in millions CAD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Revenue	21.13	25.39	16.51	19.08	18.59	10.52
Revenue Growth (YoY)	-9.54%	53.77%	-13.43%	2.60%	76.66%	-21.53%
Cost of Revenue	9.35	10	9.03	7.95	7.55	5.86
Gross Profit	11.79	15.39	7.48	11.12	11.04	4.66
Selling, General & Admin	8.93	9.36	8.17	6.72	5.17	4.17
Research & Development	2.28	2.13	2.05	1.8	1.03	1.01
Operating Expenses	11.22	11.49	10.22	8.51	6.21	5.19
Operating Income	0.57	3.91	-2.74	2.61	4.84	-0.52
Interest Expense	-0.94	-0.92	-0.84	-0.83	-1.6	-1.06
Interest & Investment Income	0.56	0.69	0.46	0.08	0	-
Other Non Operating Income (Expenses)	-0	-0	-	-	-	-
EBT Excluding Unusual Items	-0.01	3.67	-3.12	1.87	3.23	-1.58
Asset Writedown	-	-	3.08	-	-	-3.08
Other Unusual Items	-0.17	-	-	-	-	-
Pretax Income	-0.17	3.67	-0.04	1.87	3.23	-4.66
Income Tax Expense	0.15	0.15	-	0.08	-	1.57
Net Income	-0.32	3.52	-0.04	1.79	3.23	-6.23
Net Income to Common	-0.32	3.52	-0.04	1.79	3.23	-6.23
Net Income Growth	-	-	-	-44.68%	-	-
Shares Outstanding (Basic)	139	137	138	135	115	105
Shares Outstanding (Diluted)	139	137	138	142	142	105
Shares Change (YoY)	1.23%	-0.30%	-2.67%	0.00%	35.14%	7.99%
EPS (Basic)	-0.00	0.03	-0.00	0.01	0.03	-0.06
EPS (Diluted)	-0.00	0.03	-0.00	0.01	0.03	-0.06
EPS Growth	-	-	-	-49.98%	-	-
Free Cash Flow	-0.27	2.71	-2.11	1.44	0.86	-0.8
Free Cash Flow Per Share	-0.00	0.02	-0.01	0.01	0.01	-0.01
Gross Margin	55.77%	60.61%	45.30%	58.32%	59.40%	44.28%
Operating Margin	2.70%	15.38%	-16.57%	13.68%	26.01%	-4.98%
Profit Margin	-1.54%	13.86%	-0.24%	9.38%	17.39%	-59.17%
Free Cash Flow Margin	-1.28%	10.68%	-12.78%	7.55%	4.65%	-7.64%
EBITDA	1.72	5.2	-1.9	3.33	5.39	-0.1
EBITDA Margin	8.14%	20.49%	-11.48%	17.45%	28.97%	-0.91%
D&A For EBITDA	1.15	1.3	0.84	0.72	0.55	0.43
EBIT	0.57	3.91	-2.74	2.61	4.84	-0.52
EBIT Margin	2.70%	15.38%	-16.57%	13.68%	26.01%	-4.98%
Effective Tax Rate	-	4.10%	-	4.14%	-	-
Revenue as Reported	21.13	25.39	16.51	19.08	18.59	10.52

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.